What adjustments to basal rates and correction factor should be made for a patient using a Tandem insulin pump who has persistent daytime hyperglycemia, given current basal settings of 1.8 U/h from 11 pm to midnight and 2.6 U/h from 6 am to 12 pm, correction factors of 1:20 at midnight and 1:13 during the day, and with Control‑IQ enabled?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Strengthen the Correction Factor First, Then Adjust Basal Rates

For persistent daytime hyperglycemia with Control-IQ enabled, the most impactful adjustment is to make the correction factor more aggressive (stronger), followed by increasing daytime basal rates if needed. 1

Primary Recommendation: Optimize Correction Factor

The correction factor (insulin sensitivity factor) is the single most powerful lever to improve time-in-range in Control-IQ users without significantly increasing hypoglycemia risk 1. Your current daytime correction factor of 1:13 means 1 unit of insulin lowers blood glucose by 13 mg/dL.

Action steps:

  • Strengthen the daytime correction factor from 1:13 to approximately 1:10-1:11 (meaning each unit drops glucose more, so the system delivers more corrective insulin)
  • This allows Control-IQ's automated corrections and Autobolus feature (which delivers up to once per hour) to be more aggressive in bringing down elevated glucose 2
  • The real-world data from over 20,000 Control-IQ users demonstrates that more aggressive correction factors predict higher time-in-range with only negligible impact on hypoglycemia 1

Secondary Adjustment: Increase Daytime Basal Rates

After optimizing the correction factor, if hyperglycemia persists:

Increase the 6 AM to 12 PM basal rate from 2.6 U/h by 10-20% (to approximately 2.9-3.1 U/h) 3, 4

  • Most patients require only 1-2 basal rate segments, so your current setup is appropriate 5
  • Make conservative adjustments of 10% at a time and reassess after 3-5 days 4
  • Higher basal rates do predict increased time-in-range but carry slightly more hypoglycemia risk than correction factor adjustments 1

Critical Considerations for Control-IQ Systems

Understand what Control-IQ can and cannot adjust: 3

  • Control-IQ automatically modulates basal insulin delivery every 5 minutes and delivers automated correction boluses
  • The system's aggressiveness depends entirely on your programmed settings (basal rates, correction factors, carb ratios)
  • If your baseline settings are too conservative, Control-IQ cannot overcome inadequate dosing

Ensure manual mode settings are updated: 3

  • When Control-IQ reverts to manual mode (sensor issues, system alerts), it uses your programmed basal rates
  • These should reflect current insulin needs, not outdated conservative settings

Common Pitfalls to Avoid

  1. Don't assume the algorithm will fix everything - Control-IQ works within the constraints of your programmed settings 3
  2. Don't adjust too many parameters simultaneously - Change correction factor first, assess for 3-5 days, then adjust basal if needed 1, 4
  3. Don't forget about bolusing - The number of user-initiated meal boluses per day is the strongest predictor of glycemic outcomes, even more than pump settings 1

Monitoring Response

After strengthening the correction factor:

  • Review CGM data after 3-5 days focusing on daytime time-in-range (70-180 mg/dL)
  • Check for any increase in time below 70 mg/dL (should be minimal with correction factor changes) 1
  • If daytime hyperglycemia persists despite optimized correction factor, then proceed with basal rate increases

The evidence strongly supports that correction factor optimization is both safer and more effective than basal rate adjustments alone for Control-IQ users 1, making this the logical first intervention for persistent daytime hyperglycemia.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.